APO RESEARCH · REPORT
Specialty Drug Distribution
Specialty distributor handle distribution to smaller specialty pharmacies and retail pharmacies.
Product & engineering
Understand the product.
Specialty distributor handle distribution to smaller specialty pharmacies and retail pharmacies.
It is common for each specialty pharmaceutical product to have its own go-to-market strategy. Because of the unique specialty drug product specifications, therapy regimens, drug product handling, storage and transportation requirements, pricing, reimbursement and other factors, drug distribution channels and methodologies are impacted and must be considered prior to product launch. Specialty drugs do not necessarily flow directly downstream to the patient via the dispensing pharmacist. Pharmacy benefit-controlled specialty drugs can be more tightly controlled in real time, improving the payers’ ability to track utilization.
Specialty drugs are produced by specialty pharmaceutical manufacturers then sent to specialty distributors or large specialty pharmacies. From there, they may be distributed directly to patients or be sent to retail pharmacies. Specialty drugs play an increasingly important role in the treatment of chronic conditions such as multiple sclerosis (MS), rheumatoid arthritis (RA), psoriasis, and inflammatory bowel disease (IBD), etc.
Selected research
Market Structure
Global Specialty Drug Distribution Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Specialty distributor handle distribution to smaller specialty pharmacies and retail pharmacies.
It is common for each specialty pharmaceutical product to have its own go-to-market strategy. Because of the unique specialty drug product specifications, therapy regimens, drug product handling, storage and transportation requirements, pricing, reimbursement and other factors, drug distribution channels and methodologies are impacted and must be considered prior to product launch. Specialty drugs do not necessarily flow directly downstream to the patient via the dispensing pharmacist. Pharmacy benefit-controlled specialty drugs can be more tightly controlled in real time, improving the payers’ ability to track utilization.
Specialty drugs are produced by specialty pharmaceutical manufacturers then sent to specialty distributors or large specialty pharmacies. From there, they may be distributed directly to patients or be sent to retail pharmacies. Specialty drugs play an increasingly important role in the treatment of chronic conditions such as multiple sclerosis (MS), rheumatoid arthritis (RA), psoriasis, and inflammatory bowel disease (IBD), etc.
Read the full market overview
Global Specialty Drug Distribution key players include Amerisource, Mckesson, Cardinal Health, PHOENIX group, etc.
North America is the largest market, with a share about 55%, followed by Europe, and Asia-Pacific, both have a share over 35 percent.
In terms of product, Oncology is the largest segment, with a share over 50%. And in terms of application, the largest application is Hospital and Clinics, followed by Pharmacy, etc.
Report Includes
This report provides an overview of the global Specialty Drug Distribution market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Specialty Drug Distribution and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Specialty Drug Distribution revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Specialty Drug Distribution market size, projected growth trends, production technologies, key applications, and end-use industries.
Specialty Drug Distribution Segment by Company
AmerisourceBergen
Mckesson
Cardinal Health
Phoenix
Medipal Holdings
Alliance Healthcare
Sinopharm
Express Scripts
Shanghai Pharma
Anda
Jointown
Max Pharma
Specialty Drug Distribution Segment by Type
Oncology
Rheumatoid Arthritis
Multiple Sclerosis
Hemophilia
Others
Specialty Drug Distribution Segment by Application
Hospital and Clinic
Pharmacy
Others
Specialty Drug Distribution Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Specialty Drug Distribution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Specialty Drug Distribution and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Specialty Drug Distribution.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Specialty Drug Distribution in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Specialty Drug Distribution industry.
Chapter 3: Detailed analysis of Specialty Drug Distribution companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Specialty Drug Distributionrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Oncology
- Rheumatoid Arthritis
- Multiple Sclerosis
- Hemophilia
- Others
Applications
- Hospital and Clinic
- Pharmacy
- Others
Companies covered
- AmerisourceBergen
- Mckesson
- Cardinal Health
- Phoenix
- Medipal Holdings
- Alliance Healthcare
- Sinopharm
- Express Scripts
- Shanghai Pharma
- Anda
- Jointown
- Max Pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Specialty Drug Distribution Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Oncology
- 1.2.3 Rheumatoid Arthritis
- 1.2.4 Multiple Sclerosis
- 1.2.5 Hemophilia
- 1.2.6 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global Specialty Drug Distribution Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hospital and Clinic
- 1.3.3 Pharmacy
- 1.3.4 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Specialty Drug Distribution Growth Trends by Region
- 1.5.1 Global Specialty Drug Distribution Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Specialty Drug Distribution Market Size by Region (2021-2026)
- 1.5.3 Specialty Drug Distribution Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Specialty Drug Distribution Market Dynamics
- 2.1 Specialty Drug Distribution Industry Trends
- 2.2 Specialty Drug Distribution Industry Drivers
- 2.3 Specialty Drug Distribution Industry Opportunities and Challenges
- 2.4 Specialty Drug Distribution Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Specialty Drug Distribution Revenue by Company (2021-2026)
- 3.2 Global Specialty Drug Distribution Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Specialty Drug Distribution Key Company Head office and Area Served
- 3.4 Global Specialty Drug Distribution Company, Product Type & Application
- 3.5 Global Specialty Drug Distribution Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Specialty Drug Distribution Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Specialty Drug Distribution Players Market Share by Revenue in 2025
- 3.6.3 2025 Specialty Drug Distribution Tier 1, Tier 2, and Tier 3
4 Specialty Drug Distribution Market by Type
- 4.1 Global Specialty Drug Distribution Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Specialty Drug Distribution Market Size by Type (2021-2032)
- 4.3 Global Specialty Drug Distribution Market Size Share by Type (2021-2032)
5 Specialty Drug Distribution Market by Application
- 5.1 Global Specialty Drug Distribution Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Specialty Drug Distribution Market Size by Application (2021-2032)
- 5.3 Global Specialty Drug Distribution Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 AmerisourceBergen
- 6.1.1 AmerisourceBergen Company Information
- 6.1.2 AmerisourceBergen Business Overview
- 6.1.3 AmerisourceBergen Specialty Drug Distribution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 AmerisourceBergen Specialty Drug Distribution Product Portfolio
- 6.1.5 AmerisourceBergen Recent Developments
- 6.2 Mckesson
- 6.2.1 Mckesson Company Information
- 6.2.2 Mckesson Business Overview
- 6.2.3 Mckesson Specialty Drug Distribution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Mckesson Specialty Drug Distribution Product Portfolio
- 6.2.5 Mckesson Recent Developments
- 6.3 Cardinal Health
- 6.3.1 Cardinal Health Company Information
- 6.3.2 Cardinal Health Business Overview
- 6.3.3 Cardinal Health Specialty Drug Distribution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Cardinal Health Specialty Drug Distribution Product Portfolio
- 6.3.5 Cardinal Health Recent Developments
- 6.4 Phoenix
- 6.4.1 Phoenix Company Information
- 6.4.2 Phoenix Business Overview
- 6.4.3 Phoenix Specialty Drug Distribution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Phoenix Specialty Drug Distribution Product Portfolio
- 6.4.5 Phoenix Recent Developments
- 6.5 Medipal Holdings
- 6.5.1 Medipal Holdings Company Information
- 6.5.2 Medipal Holdings Business Overview
- 6.5.3 Medipal Holdings Specialty Drug Distribution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Medipal Holdings Specialty Drug Distribution Product Portfolio
- 6.5.5 Medipal Holdings Recent Developments
- 6.6 Alliance Healthcare
- 6.6.1 Alliance Healthcare Company Information
- 6.6.2 Alliance Healthcare Business Overview
- 6.6.3 Alliance Healthcare Specialty Drug Distribution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Alliance Healthcare Specialty Drug Distribution Product Portfolio
- 6.6.5 Alliance Healthcare Recent Developments
- 6.7 Sinopharm
- 6.7.1 Sinopharm Company Information
- 6.7.2 Sinopharm Business Overview
- 6.7.3 Sinopharm Specialty Drug Distribution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Sinopharm Specialty Drug Distribution Product Portfolio
- 6.7.5 Sinopharm Recent Developments
- 6.8 Express Scripts
- 6.8.1 Express Scripts Company Information
- 6.8.2 Express Scripts Business Overview
- 6.8.3 Express Scripts Specialty Drug Distribution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Express Scripts Specialty Drug Distribution Product Portfolio
- 6.8.5 Express Scripts Recent Developments
- 6.9 Shanghai Pharma
- 6.9.1 Shanghai Pharma Company Information
- 6.9.2 Shanghai Pharma Business Overview
- 6.9.3 Shanghai Pharma Specialty Drug Distribution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Shanghai Pharma Specialty Drug Distribution Product Portfolio
- 6.9.5 Shanghai Pharma Recent Developments
- 6.10 Anda
- 6.10.1 Anda Company Information
- 6.10.2 Anda Business Overview
- 6.10.3 Anda Specialty Drug Distribution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Anda Specialty Drug Distribution Product Portfolio
- 6.10.5 Anda Recent Developments
- 6.11 Jointown
- 6.11.1 Jointown Company Information
- 6.11.2 Jointown Business Overview
- 6.11.3 Jointown Specialty Drug Distribution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Jointown Specialty Drug Distribution Product Portfolio
- 6.11.5 Jointown Recent Developments
- 6.12 Max Pharma
- 6.12.1 Max Pharma Company Information
- 6.12.2 Max Pharma Business Overview
- 6.12.3 Max Pharma Specialty Drug Distribution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Max Pharma Specialty Drug Distribution Product Portfolio
- 6.12.5 Max Pharma Recent Developments
7 North America
- 7.1 North America Specialty Drug Distribution Market Size (2021-2032)
- 7.2 North America Specialty Drug Distribution Market Size by Type
- 7.2.1 North America Specialty Drug Distribution Market Size by Type (2021-2026)
- 7.2.2 North America Specialty Drug Distribution Market Size by Type (2027-2032)
- 7.2.3 North America Specialty Drug Distribution Market Share by Type (2021-2032)
- 7.3 North America Specialty Drug Distribution Market Size by Application
- 7.3.1 North America Specialty Drug Distribution Market Size by Application (2021-2026)
- 7.3.2 North America Specialty Drug Distribution Market Size by Application (2027-2032)
- 7.3.3 North America Specialty Drug Distribution Market Share by Application (2021-2032)
- 7.4 North America Specialty Drug Distribution Market Size by Country
- 7.4.1 North America Specialty Drug Distribution Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Specialty Drug Distribution Market Size by Country (2021-2026)
- 7.4.3 North America Specialty Drug Distribution Market Size by Country (2027-2032)
- 7.4.4 North America Specialty Drug Distribution Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Specialty Drug Distribution Market Size (2021-2032)
- 8.2 Europe Specialty Drug Distribution Market Size by Type
- 8.2.1 Europe Specialty Drug Distribution Market Size by Type (2021-2026)
- 8.2.2 Europe Specialty Drug Distribution Market Size by Type (2027-2032)
- 8.2.3 Europe Specialty Drug Distribution Market Share by Type (2021-2032)
- 8.3 Europe Specialty Drug Distribution Market Size by Application
- 8.3.1 Europe Specialty Drug Distribution Market Size by Application (2021-2026)
- 8.3.2 Europe Specialty Drug Distribution Market Size by Application (2027-2032)
- 8.3.3 Europe Specialty Drug Distribution Market Share by Application (2021-2032)
- 8.4 Europe Specialty Drug Distribution Market Size by Country
- 8.4.1 Europe Specialty Drug Distribution Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Specialty Drug Distribution Market Size by Country (2021-2026)
- 8.4.3 Europe Specialty Drug Distribution Market Size by Country (2027-2032)
- 8.4.4 Europe Specialty Drug Distribution Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Specialty Drug Distribution Market Size (2021-2032)
- 9.2 China Specialty Drug Distribution Market Size by Type
- 9.2.1 China Specialty Drug Distribution Market Size by Type (2021-2026)
- 9.2.2 China Specialty Drug Distribution Market Size by Type (2027-2032)
- 9.2.3 China Specialty Drug Distribution Market Share by Type (2021-2032)
- 9.3 China Specialty Drug Distribution Market Size by Application
- 9.3.1 China Specialty Drug Distribution Market Size by Application (2021-2026)
- 9.3.2 China Specialty Drug Distribution Market Size by Application (2027-2032)
- 9.3.3 China Specialty Drug Distribution Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Specialty Drug Distribution Market Size (2021-2032)
- 10.2 Asia Specialty Drug Distribution Market Size by Type
- 10.2.1 Asia Specialty Drug Distribution Market Size by Type (2021-2026)
- 10.2.2 Asia Specialty Drug Distribution Market Size by Type (2027-2032)
- 10.2.3 Asia Specialty Drug Distribution Market Share by Type (2021-2032)
- 10.3 Asia Specialty Drug Distribution Market Size by Application
- 10.3.1 Asia Specialty Drug Distribution Market Size by Application (2021-2026)
- 10.3.2 Asia Specialty Drug Distribution Market Size by Application (2027-2032)
- 10.3.3 Asia Specialty Drug Distribution Market Share by Application (2021-2032)
- 10.4 Asia Specialty Drug Distribution Market Size by Country
- 10.4.1 Asia Specialty Drug Distribution Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Specialty Drug Distribution Market Size by Country (2021-2026)
- 10.4.3 Asia Specialty Drug Distribution Market Size by Country (2027-2032)
- 10.4.4 Asia Specialty Drug Distribution Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Specialty Drug Distribution Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Specialty Drug Distribution Market Size by Type
- 11.2.1 South America, Middle East & Africa Specialty Drug Distribution Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Specialty Drug Distribution Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Specialty Drug Distribution Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Specialty Drug Distribution Market Size by Application
- 11.3.1 South America, Middle East & Africa Specialty Drug Distribution Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Specialty Drug Distribution Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Specialty Drug Distribution Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Specialty Drug Distribution Market Size by Country
- 11.4.1 South America, Middle East & Africa Specialty Drug Distribution Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Specialty Drug Distribution Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Specialty Drug Distribution Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Specialty Drug Distribution Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst